Back
Lyra Therapeutics, Inc. Stock Price Chart
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
23
LYRA
Lyra Therapeutics, Inc.
Last Price:
$3.60
Seasonality Move:
3.74%
7 Day Trial
ALL ACCESS PASS
$
7
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LYRA is experiencing selling pressure, which indicates risk of future bearish movement.
Lyra Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.07 | Sell |
| 20-day SMA: | 3.72 | Sell |
| 50-day SMA: | 5.24 | Sell |
| 200-day SMA: | 7.24 | Sell |
| 8-day EMA: | 3.92 | Sell |
| 20-day EMA: | 4.04 | Sell |
| 50-day EMA: | 4.87 | Sell |
| 200-day EMA: | 11.04 | Sell |
Lyra Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.28 | Sell |
| Relative Strength Index (14 RSI): | 38.76 | Sell |
| Chaikin Money Flow: | -40480 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.38 - 4.26) | Sell |
| Bollinger Bands (100): | (4.63 - 7.47) | Sell |
Lyra Therapeutics, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Lyra Therapeutics, Inc. Stock
Is Lyra Therapeutics, Inc. Stock a Buy?
-
Lyra Therapeutics, Inc. share price is 3.64 while LYRA 8-day simple moving average is 4.07, which is a Sell signal.
-
The stock price of LYRA is 3.64 while Lyra Therapeutics, Inc. 20-day SMA is 3.72, which makes it a Sell.
-
Lyra Therapeutics, Inc. 50-day simple moving average is 5.24 while LYRA share price is 3.64, making it a Sell technically.
-
LYRA stock price is 3.64 and Lyra Therapeutics, Inc. 200-day simple moving average is 7.24, creating a Sell signal.
LYRA Technical Analysis vs Fundamental Analysis
Sell
23
Lyra Therapeutics, Inc. (LYRA)
is a Sell
Is Lyra Therapeutics, Inc. a Buy or a Sell?
-
Lyra Therapeutics, Inc. stock is rated a SellThe current Lyra Therapeutics, Inc. [LYRA] share price is $3.64. The Score for LYRA is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
Lyra Therapeutics, Inc. Stock Info
Market Cap:
4.8M
Price in USD:
3.64
Share Volume:
65.1K
Lyra Therapeutics, Inc. 52-Week Range
52-Week High:
37.50
52-Week Low:
2.84
Sell
23
Lyra Therapeutics, Inc. (LYRA)
is a Sell
Lyra Therapeutics, Inc. Share Price Forecast
-
What is the Lyra Therapeutics, Inc. stock price today?The Lyra Therapeutics, Inc. stock price is 3.64 USD today.
-
Will LYRA stock go up or go down?Lyra Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Lyra Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Lyra Therapeutics, Inc. is overvalued.
Is Lyra Therapeutics, Inc. Stock a Buy?
-
Lyra Therapeutics, Inc. share price is 3.64 while LYRA 8-day exponential moving average is 3.92, which is a Sell signal.
-
The stock price of LYRA is 3.64 while Lyra Therapeutics, Inc. 20-day EMA is 4.04, which makes it a Sell.
-
Lyra Therapeutics, Inc. 50-day exponential moving average is 4.87 while LYRA share price is 3.64, making it a Sell technically.
-
LYRA stock price is 3.64 and Lyra Therapeutics, Inc. 200-day simple moving average is 11.04, creating a Sell signal.
Fundamental Analysis of Lyra Therapeutics, Inc.
Is Lyra Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $62.25 per share, and an increase next year of $0.51 per share.
Technical Analysis of Lyra Therapeutics, Inc.
Should I short Lyra Therapeutics, Inc. stock?
-
LYRA Moving Average Covergence Divergence (MACD) indicator is -0.28, suggesting Lyra Therapeutics, Inc. is a Sell
-
Lyra Therapeutics, Inc. Relative Strength Index (RSI) is 38.76, which suggest Lyra Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Lyra Therapeutics, Inc. is (3.38 - 4.26), which suggest Lyra Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Lyra Therapeutics, Inc. is (4.63 - 7.47), which suggest Lyra Therapeutics, Inc. is a Sell
* Lyra Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.